Navigation Links
Long Patient Waiting Times Force NHS Patients To Seek Treatment Abroad

Looks like it is time for impatient patients to travel abroad rather than wait for weeks or months to get treated// for their ailments. Recently, a woman won the right to claim compensation from the NHS for a hip replacement surgery done abroad. In yet another case, a 63-year-old British woman who traveled elsewhere gave birth to a baby, after prenatal diagnostic tests confirmed absence of any genetic disorder.

A recent case that stirred controversy was the one involving Yvonne Watts, who got her hip replacement surgery in France, tired of waiting for surgery in UK. She had claimed the amount she had paid for the surgery (£3,900) from Bedford Primary Care Trust. The court apparently ruled that she could claim the money if she could prove the delay in provision of treatment.

Such legal decisions should be made on the basis of the merits of the treatment and the condition of the patient. Owing to such case that have caught public attention, the waiting times of patients registered with the NHS are coming down.

If only the Government reaches its target of 18 weeks (from the time of referral to provision of treatment) by the end of 2008, then perhaps the need for NHS patients to travel abroad for medical treatment would be drastically reduced.

One reason behind the increasing inclination to medical tourism is also the reduced cost associated with cosmetic surgery, infertility treatment (more specifically, IVF), orthopedic surgeries such as knee and hip replacement surgeries in other countries compared to NHS costs. Countries such as India, South Africa, Malaysia, Eastern Europe and Thailand are particularly enjoying the growth of the medical tourism industry.


'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patient’s perception of health status helps in better recover
7. Patients often assume wrongly that they are allergic to penicillin
8. New FDA Approved Drug NATRECOR For Heart Failure Patients
9. Hemochromatosis Patients Blood is Safe
10. Fifth US Patient Receives Artificial Heart
11. Patients Pressure Would Result In Overprescription
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/17/2017)... ... January 17, 2017 , ... Mirror Mirror Beauty Boutique, ... highest honor of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, ... this elite group of providers. , Produced by Zeltiq, CoolSculpting is approved by ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... will lecture to primary eye care practitioners on the latest breakthroughs in the ... 13th Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, ...
(Date:1/17/2017)... ... January 17, 2017 , ... Neil H. Greco Insurance Agency, a northern New ... the region, is launching a charity drive to raise awareness of heart disease and ... killer in America, and is responsible for 1 in every 4 deaths at the ...
(Date:1/17/2017)... ... January 17, 2017 , ... Livionex, Inc., a Silicon Valley ... double blind clinical study for its dental gel that shows significant reduction in plaque ... toothpaste containing triclosan. The study was conducted at the Beckman Laser Institute at UC ...
(Date:1/17/2017)... Tyler, TX (PRWEB) , ... January 17, 2017 ... ... serving Texas families from two offices in Tyler, has announced the latest beneficiary ... Red Ribbon Wish Network, a nonprofit organization dedicated to fulfilling the dreams of ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... 17, 2017   Tocagen Inc ., a clinical-stage, cancer-selective gene ... vice president, research and pharmaceutical development at Tocagen, will present at ... held Jan. 17-20 in Miami . ... ... manufacturing for replicating viruses - what to do when and why ...
(Date:1/17/2017)... Jan 17, 2017 Research and Markets has ... Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, ... Forecast to 2021" report to their offering. ... The global active pharmaceutical ingredients ... USD 157.95 Billion in 2016, growing at a CAGR of 6.3% ...
(Date:1/17/2017)... , Jan. 17, 2017 Immune Pharmaceuticals (NASDAQ: ... company, announced today that it will hold a Satellite Symposium ... Acute Leukemias (ISAL) XVI in Munich, Germany ... "Reinforcing the Efficacy of Immunotherapy for the maintenance of ... on Monday February 20 th , 2017 from 12:45 – ...
Breaking Medicine Technology: